Loading company…
Senzo, Inc., based in Newtown Square, develops rapid point-of-care diagnostic tests, including its Amplified Lateral Flow test.
Founded in 2014 in Newtown Square, US, Senzo, Inc. develops point-of-care diagnostics, mainly its Amplified Lateral Flow test for infectious diseases such as COVID-19, HIV and tuberculosis. The products are sold to healthcare providers, laboratories and institutions, and the company has partnerships with organizations including BARDA. In October 2023 it raised USD 1.8 mn in a Seed round at a post-money valuation of USD 24.70 mn. It has completed six deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in